Foxn1, short for Forkhead box N1, belongs to a large family of transcription factors that bind DNA and switch other genes on or off. The gene first earned scientific fame because mutations in it cause nude mice to be hairless and immune-deficient, a phenotype traced to failed development of the thymus and hair follicles. In humans, mutations in FOXN1 produce a rare form of severe combined immunodeficiency accompanied by alopecia and nail dystrophy. What the new study adds is a systematic portrait of what happens when Foxn1 dosage is halved in otherwise healthy animals and how that half-dose interacts with aging itself.

The researchers worked with three groups of animals: young mice at twenty days of age, middle-aged mice at one year, and old mice at two years. At each time point they compared wild-type animals, carrying two normal copies of Foxn1, with heterozygous knockout animals carrying only one. Because no live-animal procedures were involved, the team collected tissue post-mortem, in accordance with European Directive 2010/63/EU. They then applied a battery of techniques ranging from histology and immunofluorescence to western blotting and quantitative PCR, supplemented by liquid chromatography with tandem mass spectrometry, to build a layered picture of gene expression, protein abundance, and tissue structure.

The morphological differences were striking. Skin from the heterozygous animals had a thinner epidermis and a thicker dermis than that of their wild-type counterparts. Within the epidermis, keratinocyte differentiation was disrupted, with an enlarged spinous layer dominating the tissue. The spinous layer is the thick middle stratum of the epidermis where differentiating keratinocytes are held together by numerous desmosomes, giving the cells their spiny appearance under the microscope. Its expansion in Foxn1 haploinsufficient mice points to a shift in how basal cells exit the proliferative compartment and mature into the protective barrier layers above, a process governed by a finely tuned sequence of lineage-specific keratins and terminal differentiation markers such as keratin 10, loricrin, and filaggrin.

Collagen composition told an equally intriguing story. Wild-type skin accumulated more collagen I, the stiff, rope-like fiber that provides tensile strength and is characteristic of mature, repair-oriented extracellular matrix. Heterozygous skin, by contrast, maintained elevated levels of collagen III, the thinner, more pliable fiber that dominates embryonic and regenerative tissue and is normally replaced by collagen I during scar maturation. This shift hints that reduced Foxn1 dosage preserves a more regeneration-friendly matrix profile, a property of considerable interest for wound-healing and anti-aging research, where the goal is often to coax adult skin back toward a fetal-like repair mode rather than a scarring one.

Perhaps the most consequential finding concerned cellular senescence, the state of stable cell-cycle arrest that accumulates in aging tissues and drives inflammation through the molecules senescent cells secrete. The team measured expression of p21, encoded by the Cdkn1a gene, a canonical readout of senescence signaling. In wild-type mice, p21 expression climbed steadily with age, exactly as expected for tissue progressively filling with senescent cells. In the heterozygous mice, however, p21 remained low even in aged animals, suggesting that halving Foxn1 dosage fundamentally alters the senescence pathway in skin. The authors are careful to frame this as an altered trajectory rather than proven rejuvenation, but the implication is provocative: a transcription factor could reprogram how skin cells respond to the molecular damage of time.

Foxn1 also emerged as a modulator of the hypoxia response and of redox homeostasis, the biochemical balancing act between reactive oxygen species and the antioxidant systems that neutralize them. Reactive oxygen species are unavoidable byproducts of mitochondrial metabolism and, when unchecked, damage lipids, proteins, and DNA, making redox balance a cornerstone of aging biology. The researchers examined HIF-1α, the hypoxia-inducible factor that coordinates cellular responses to low oxygen, along with factor inhibiting HIF-1, the oxygen-dependent hydroxylase that switches HIF signaling off. They also profiled the thioredoxin system, including thioredoxins 1 and 2 and their reductases Txnrd1 through Txnrd3, plus sulfiredoxin 1, all central components of the cellular antioxidant arsenal. Differences in these pathways between the genotypes were most pronounced in young and middle-aged animals, and notably faded in the oldest group.

That age-dependent fading is itself an important message. The regulatory influence of Foxn1 on hypoxia signaling, oxidative stress, and cellular protection appears strongest when the skin is still youthful and wanes as animals reach advanced age. In other words, Foxn1 behaves like an age-sensitive governor: in early and mid-life it helps hold skin homeostasis in check, but by two years of age its grip loosens, and the aging phenotype proceeds regardless of genotype. This dynamic complicates any simple therapeutic narrative, because simply knowing that a gene matters is not enough; the timing of its activity defines when an intervention might work.

The study also documented Foxn1 protein inside epidermal keratinocytes and hair follicles in both genotypes and at all three ages, using immunofluorescence and transgenic FOXN1::eGFP reporter mice generously provided by Professor Thomas Boehm of the Max Planck Institute of Immunobiology and Epigenetics. The nuclear localization of the protein within keratinocytes is consistent with its established function as a DNA-binding transcription factor and supports the idea that Foxn1 acts directly within the epidermal lineage rather than merely indirectly through immune or dermal effects. Hair follicle counts in the dermis and in the dermal white adipose tissue, the fat layer under the skin that hosts follicle bulges, further mapped how structural changes distribute across skin compartments with age and genotype.

For a broad audience, the takeaway is that skin aging is not a one-way slide but a genetically choreographed process with named conductors. Foxn1 now joins the short list of genes whose dosage measurably reshapes tissue structure, extracellular matrix composition, senescence signaling, and stress responses in an intact aging organism. Because the work was performed in mice, translating it to human skin will require caution; human and murine skin differ in thickness, follicle density, and immune composition. Still, the identification of a single transcription factor whose partial loss keeps p21 low and preserves a regenerative collagen profile gives aging researchers a concrete molecular handle. Whether pharmacologically tuning Foxn1 activity could one day slow skin aging or improve wound repair remains an open question, but this study transforms it from speculation into a testable hypothesis, and it does so with the kind of multi-system, age-resolved evidence that the field has long demanded.

Subject of Research: The role of the Foxn1 transcription factor in skin structure, redox balance, and aging

Article Title: Foxn1 regulates epidermal structure, redox balance, and age related changes

Article References: Machcinska-Zielinska, S., Kopcewicz, M., Wisniewska, J., Valdivieso, K., Ogrodnik, M., Walendzik, K., & Gawronska-Kozak, B. (2026). Foxn1 regulates epidermal structure, redox balance, and age related changes. BMC Biology. https://doi.org/10.1186/s12915-026-02737-x

Image Credits: AI Generated

DOI: 10.1186/s12915-026-02737-x

Keywords: Foxn1, skin aging, epidermis, keratinocytes, collagen, redox homeostasis, reactive oxygen species, senescence, p21, HIF-1 alpha, thioredoxin, mice